- Latest available (Revised)
- Original (As adopted by EU)
Council Decision of 20 December 2012 appointing four members of the Management Board of the European Medicines Agency (EMA) (2013/33/EU)
You are here:
- Decisions originating from the EU
- 2013 No. 33
- Whole Decision
- Previous
- Next
What Version
Opening Options
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Status:
This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version
Council Decision
of 20 December 2012
appointing four members of the Management Board of the European Medicines Agency (EMA)
(2013/33/EU)
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency(1), and in particular Article 65(1) and (4) thereof,
Having regard to the list of candidates drawn up by the Commission on 8 August 2012,
Having regard to the opinion of the European Parliament,
HAS ADOPTED THIS DECISION:
Article 1
Nikolaos DEDES, born on 15 December 1966, Christophe HUGNET, born on 1 February 1971, Wolf-Dieter LUDWIG, born on 31 January 1952, and Wim WIENTJES, born on 16 September 1937 shall be appointed as members of the Management Board of the European Medicines Agency for a period of three years.
Article 2
The date on which the three-year period referred to in Article 1 will commence shall be determined by the Management Board of the European Medicines Agency.
Done at Brussels, 20 December 2012.
For the Council
The President
E. Flourentzou
Options/Help
Print Options
PrintThe Whole Decision
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
The data on this page is available in the alternative data formats listed:
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.